The max response date on the original submission would be March 27, but the CEO referenced late March. Many of the first applications received an earlier response that the full 60, so I wouldn't count on the full May 27 theoretical final response date. It could come at any time, or have already arrived.
Also, fwiw Bioheart clinical trial #6 was updated on March 23, per the NIH. Given MyoCell was updated Jan 30 originally, we could be due a response on another treatment as well. Wouldn't that be a nice surprise?
News 
Market Data 
Discover 
